Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 44
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving the most endangered seabird in the Americas

    Seven years of intense field monitoring and automated recordings, showed us which factors negatively impact...

    What environmental factors control lichen form throughout the redwood canopy?

    High up in California's coast redwoods, lichens vary in reproductive form throughout the canopy. The species...

    Backer Badge Funded